These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8615189)

  • 1. Genetic linkage studies in autosomal dominantly inherited L-DOPA responsive parkinsonism. Evaluation of candidate genes.
    Gasser T; Wszolek Z; Supala A; Trofatter J; Ozelius L; Uitti RJ; Pfeiffer RF; Gusella J; Calne D; Breakefield XO
    Adv Neurol; 1996; 69():87-95. PubMed ID: 8615189
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic linkage studies in autosomal dominant parkinsonism: evaluation of seven candidate genes.
    Gasser T; Wszolek ZK; Trofatter J; Ozelius L; Uitti RJ; Lee CS; Gusella J; Pfeiffer RF; Calne DB; Breakefield XO
    Ann Neurol; 1994 Sep; 36(3):387-96. PubMed ID: 7915897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early-onset parkinsonism with dystonia. Clinical and biochemical differences from hereditary progressive dystonia or DOPA-responsive dystonia.
    Furukawa Y; Mizuno Y; Narabayashi H
    Adv Neurol; 1996; 69():327-37. PubMed ID: 8615147
    [No Abstract]   [Full Text] [Related]  

  • 4. A family with hereditary juvenile dystonia-parkinsonism.
    Ishikawa A; Miyatake T
    Mov Disord; 1995 Jul; 10(4):482-8. PubMed ID: 7565830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levodopa response in Parkinsonism with multiple mitochondrial DNA deletions.
    Wilcox RA; Churchyard A; Dahl HH; Hutchison WM; Kirby DM; Thyagarajan D
    Mov Disord; 2007 May; 22(7):1020-3. PubMed ID: 17357142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Greek-American kindred with autosomal dominant, levodopa-responsive parkinsonism and anticipation.
    Markopoulou K; Wszolek ZK; Pfeiffer RF
    Ann Neurol; 1995 Sep; 38(3):373-8. PubMed ID: 7668822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopa-responsive, nonprogressive juvenile parkinsonism: report of a case.
    Rajput A; Kishore A; Snow B; Bolton CF; Rajput AH
    Mov Disord; 1997 May; 12(3):453-6. PubMed ID: 9159748
    [No Abstract]   [Full Text] [Related]  

  • 8. SCA2 may present as levodopa-responsive parkinsonism.
    Payami H; Nutt J; Gancher S; Bird T; McNeal MG; Seltzer WK; Hussey J; Lockhart P; Gwinn-Hardy K; Singleton AA; Singleton AB; Hardy J; Farrer M
    Mov Disord; 2003 Apr; 18(4):425-9. PubMed ID: 12671950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autosomal dominant dopa-responsive parkinsonism in a multigenerational Swiss family.
    Wider C; Skipper L; Solida A; Brown L; Farrer M; Dickson D; Wszolek ZK; Vingerhoets FJ
    Parkinsonism Relat Disord; 2008 Aug; 14(6):465-70. PubMed ID: 18342564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopa responsive dystonia and juvenile Parkinson's disease: two subtypes of the same disorder?
    Lamberti P; de Mari M; Iliceto G; Federico F
    Acta Neurol (Napoli); 1992; 14(4-6):451-4. PubMed ID: 1293988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphism of the angiotensin converting enzyme and L-dopa-induced adverse effects in Parkinson's disease.
    Lin JJ; Yueh KC; Lin SZ; Harn HJ; Liu JT
    J Neurol Sci; 2007 Jan; 252(2):130-4. PubMed ID: 17196621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary spastic paraplegia associated with dopa-responsive parkinsonism.
    Micheli F; Cersósimo MG; Zúñiga Ramírez C
    Mov Disord; 2006 May; 21(5):716-7. PubMed ID: 16463348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levodopa-dyskinesia incidence by age of Parkinson's disease onset.
    Kumar N; Van Gerpen JA; Bower JH; Ahlskog JE
    Mov Disord; 2005 Mar; 20(3):342-4. PubMed ID: 15580606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autosomal dominant familial Parkinson disease: older onset of age, and good response to levodopa therapy.
    Hasegawa K; Kowa H
    Eur Neurol; 1997; 38 Suppl 1():39-43. PubMed ID: 9276200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-dopa slows the progression of familial parkinsonism.
    Gwinn-Hardy K; Evidente VG; Waters C; Muenter MD; Hardy J
    Lancet; 1999 May; 353(9167):1850-1. PubMed ID: 10359414
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of monoamine oxidase B (MAOB) and catechol-O-methyltransferase (COMT) polymorphisms on levodopa therapy in patients with sporadic Parkinson's disease.
    Białecka M; Droździk M; Kłodowska-Duda G; Honczarenko K; Gawrońska-Szklarz B; Opala G; Stankiewicz J
    Acta Neurol Scand; 2004 Oct; 110(4):260-6. PubMed ID: 15355491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dopa-therapy in the treatment of early stage Parkinson's disease].
    Broussolle E
    Rev Neurol (Paris); 2000; 156 Suppl 2 Pt 2():91-7. PubMed ID: 10916042
    [No Abstract]   [Full Text] [Related]  

  • 18. Partial trisomy 4q associated with young-onset dopa-responsive parkinsonism.
    Garraux G; Caberg JH; Vanbellinghen JF; Jamar M; Bours V; Moonen G; Dive D
    Arch Neurol; 2012 Mar; 69(3):398-400. PubMed ID: 22410449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hereditary Parkinson disease: report of 3 families with dominant autosomal inheritance].
    Wszolek ZK; Cordes M; Calne DB; Münter MD; Cordes I; Pfeifer RF
    Nervenarzt; 1993 May; 64(5):331-5. PubMed ID: 8321342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linkage studies in alcohol-responsive myoclonic dystonia.
    Gasser T; Bereznai B; Müller B; Pruszak-Seel R; Damrich R; Deuschl G; Oertel WH
    Mov Disord; 1996 Jul; 11(4):363-70. PubMed ID: 8813214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.